Revista: | Annals of hepatology |
Base de datos: | PERIÓDICA |
Número de sistema: | 000415691 |
ISSN: | 1665-2681 |
Autors: | Hegade, Vinod S1 Sood, Ruchit1 Saralaya, Dinesh1 Moreea, Sulleman1 |
Institucions: | 1Bradford Teaching Hospitals NHS Foundation Trust, Bradford Royal Infirmary, Bradford, West Yorkshire. Reino Unido |
Any: | 2013 |
Període: | Jul-Ago |
Volum: | 12 |
Número: | 4 |
Paginació: | 461-465 |
País: | México |
Idioma: | Inglés |
Tipo de documento: | Artículo |
Enfoque: | Caso clínico |
Resumen en inglés | Pegylated interferon (Peg-IFN) in combination with ribavirin is the standard of care in the treatment of chronic hepatitis C (HCV). Peg-IFN is known to have a number of side effects but severe respiratory complications are uncommon. We report two cases, one of Peg-IFN induced interstitial pneumonitis (IP) and the other of bronchiolitis obliterans organising pneumonia (BOOP) in patients with chronic hepatitis C infection. In general, respiratory complications of Peg-IFN are mild and resolve with withdrawal of Peg-IFN. However, as illustrated in our first case fatal interstitial pneumonitis can occur. We present a review of the available literature on Peg-IFN induced lung toxicity. In conclusion, pulmonary toxicity with Peg-IFN is rare but fatality can occur. We highlight the importance of maintaining a high index of suspicion for early diagnosis and prompt treatment, which includes withdrawal of Peg-IFN and consideration of corticosteroid treatment |
Disciplines | Medicina |
Paraules clau: | Farmacología, Gastroenterología, Hepatitis C, Interferón pegilado, Efectos adversos, Neumonitis intersticial, Bronquiolitis obliterante |
Keyword: | Medicine, Gastroenterology, Pharmacology, Hepatitis C, Pegylated interferon, Adverse effects, Interstitial pneumonitis, Bronchiolitis obliterans |
Text complet: | Texto completo (Ver PDF) |